Literature DB >> 11474903

Cadmium in zinc-containing mineral supplements.

C A Krone1, E J Wyse, J T Ely.   

Abstract

Seven zinc-containing dietary supplements were analyzed for zinc (Zn) and cadmium (Cd) by inductively coupled plasma/mass spectrometry (ICP/MS). Cadmium was detected in all samples; however, the amount of Cd per 15 mg Zn (the daily US Recommended Dietary Allowance) varied by over 37-fold (0.039 to 1.46 micrograms Cd/15 mg Zn). Supplements with Zn in the form of a gluconate consistently contained the lowest amounts of Cd. Because Cd is a non-essential potentially toxic element for humans, its concentration in nutritional supplements should be minimized and possibly regulated by government-established standards.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11474903     DOI: 10.1080/09637480120057602

Source DB:  PubMed          Journal:  Int J Food Sci Nutr        ISSN: 0963-7486            Impact factor:   3.833


  2 in total

Review 1.  Zinc and zinc transporters in prostate carcinogenesis.

Authors:  Vladimir Kolenko; Ervin Teper; Alexander Kutikov; Robert Uzzo
Journal:  Nat Rev Urol       Date:  2013-03-12       Impact factor: 14.432

2.  Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappaB-independent, proteasome-mediated mechanism.

Authors:  Konstantin Golovine; Peter Makhov; Robert G Uzzo; Alexander Kutikov; David J Kaplan; Eric Fox; Vladimir M Kolenko
Journal:  Mol Cancer       Date:  2010-07-09       Impact factor: 27.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.